racemetirosine has been researched along with B16 Melanoma in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A strategy for cancer therapy using astatine-211-labeled alpha-methyltyrosine (211At-AMT) was studied in cultured B16 melanoma cells and compared to the radiotoxicity of iodine-125-labeled iododeoxyuridine (125IUdR), a thymidine analogue." | 3.67 | Preliminary observations of malignant melanoma therapy using radiolabeled alpha-methyltyrosine. ( Bloomer, WD; Lambrecht, RM; McLaughlin, WH; Milius, RA; Thramann, WM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McLaughlin, WH | 1 |
| Thramann, WM | 1 |
| Lambrecht, RM | 1 |
| Milius, RA | 1 |
| Bloomer, WD | 1 |
1 other study available for racemetirosine and B16 Melanoma
| Article | Year |
|---|---|
Preliminary observations of malignant melanoma therapy using radiolabeled alpha-methyltyrosine.
Topics: alpha-Methyltyrosine; Astatine; Cell Survival; Humans; Idoxuridine; Iodine Radioisotopes; Melanoma, | 1988 |